Anti-cyclic citrullinated peptide but not rheumatoid factor is associated with ultrasound-detected bone erosion among rheumatoid arthritis patients with at least moderate disease activity
- PMID: 33460311
- DOI: 10.1111/1756-185X.13933
Anti-cyclic citrullinated peptide but not rheumatoid factor is associated with ultrasound-detected bone erosion among rheumatoid arthritis patients with at least moderate disease activity
Abstract
Aim: To investigate anti-cyclic citrullinated peptide (anti-CCP) and rheumatoid factor (RF) in relation to ultrasound-detected joint inflammation and bone erosion in patients with rheumatoid arthritis (RA) as previous studies have mainly utilized radiographic damage as imaging outcomes.
Method: In this cross-sectional study, patients were grouped based on their Disease Activity Score at 28 joints (DAS28 < 3.2, DAS28 ≥ 3.2). Ultrasound variables (power Doppler and gray scale joint inflammation graded 0-3 semi-quantitatively; bone erosion graded Yes = 1/No = 0 dichotomously) were correlated with antibodies levels using Pearson correlation. Simple linear regression was used to characterize relationships between variables. Receiver operating characteristic (ROC) analysis was performed to determine statistically optimal cut-off values for identifying patient subgroups with ultrasound erosion scores >25th, >50th and >75th percentiles.
Results: One thousand and eighty joints and 1800 joint recesses from 36 peripheral joint sites were scanned in 30 adult RA patients (mean disease duration, 70.3 months; 93.3% female; 93.3% anti-CCP positive; 93.3% RF positive). In the DAS28 < 3.2 group, no significant correlations were found between antibody levels and ultrasound variables. In the DAS28 ≥ 3.2 group, anti-CCP levels correlated significantly (r = 0.46, P = .048) and were predictive (P = .048) of ultrasound erosion scores. Area under the ROC curve based on cut-off anti-CCP level of ≥95.2 to identify patients with ultrasound erosion scores >7 (75th percentile) was 0.72 (sensitivity = 83.3%, specificity = 53.8%).
Conclusion: The association of anti-CCP and RF with joint damage appears to differ in RA. Among patients with at least moderate disease activity (DAS28 ≥ 3.2), anti-CCP-but not RF-is associated with joint damage, being moderately correlated with ultrasound-detected bone erosion.
Keywords: anti‐CCP; bone erosion; rheumatoid arthritis; rheumatoid factor; synovitis; ultrasound.
© 2020 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.
Similar articles
-
Ultrasound power Doppler and gray scale joint inflammation: What they reveal in rheumatoid arthritis.Int J Rheum Dis. 2019 Sep;22(9):1719-1723. doi: 10.1111/1756-185X.13653. Epub 2019 Jul 15. Int J Rheum Dis. 2019. PMID: 31304659
-
Receiver operating characteristic analysis of ultrasound joint inflammation in relation to structural damage and disease activity in rheumatoid arthritis.Radiol Med. 2019 Oct;124(10):1037-1042. doi: 10.1007/s11547-019-01063-3. Epub 2019 Jul 3. Radiol Med. 2019. PMID: 31270722
-
Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients.Medicine (Baltimore). 2019 Mar;98(12):e14945. doi: 10.1097/MD.0000000000014945. Medicine (Baltimore). 2019. PMID: 30896663 Free PMC article.
-
The status of rheumatoid factor and anti-cyclic citrullinated peptide antibody are not associated with the effect of anti-TNFα agent treatment in patients with rheumatoid arthritis: a meta-analysis.PLoS One. 2014 Feb 27;9(2):e89442. doi: 10.1371/journal.pone.0089442. eCollection 2014. PLoS One. 2014. PMID: 24586782 Free PMC article. Review.
-
Assessment of disease activity and treatment outcomes in rheumatoid arthritis.J Manag Care Pharm. 2011 Nov-Dec;17(9 Suppl B):S09-13. doi: 10.18553/jmcp.2011.17.s9-b.s09. J Manag Care Pharm. 2011. PMID: 22073934 Free PMC article. Review.
Cited by
-
Understanding Ultrasound Power Doppler Synovitis at Clinically Quiescent Joints and Thermographic Joint Inflammation Assessment in Patients with Rheumatoid Arthritis.Diagnostics (Basel). 2024 Oct 25;14(21):2384. doi: 10.3390/diagnostics14212384. Diagnostics (Basel). 2024. PMID: 39518352 Free PMC article.
-
Thermographic and ultrasound assessment in patients with rheumatoid arthritis: can thermography detect subclinical synovitis at the wrist?BMC Rheumatol. 2024 Nov 19;8(1):62. doi: 10.1186/s41927-024-00435-1. BMC Rheumatol. 2024. PMID: 39558420 Free PMC article.
-
The Utility of Thermography in Detecting Subclinical Joint Inflammation at the Elbows in Patients With Rheumatoid Arthritis.Int J Rheum Dis. 2024 Dec;27(12):e70015. doi: 10.1111/1756-185X.70015. Int J Rheum Dis. 2024. PMID: 39679777 Free PMC article. No abstract available.
-
A Narrative Literature Review Comparing the Key Features of Musculoskeletal Involvement in Rheumatoid Arthritis and Systemic Lupus Erythematosus.Rheumatol Ther. 2022 Jun;9(3):781-802. doi: 10.1007/s40744-022-00442-z. Epub 2022 Mar 31. Rheumatol Ther. 2022. PMID: 35359260 Free PMC article. Review.
-
Effects of the COVID-19 pandemic on psychology and disease activity in patients with ankylosing spondylitis and rheumatoid arthritis.Turk J Med Sci. 2021 Aug 30;51(4):1631-1639. doi: 10.3906/sag-2011-188. Turk J Med Sci. 2021. PMID: 33773523 Free PMC article.
References
REFERENCES
-
- van der Woude D, van der Helm-van Mil AHM. Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2018;32(2):174-187.
-
- Demoruelle MK, Deane KD. Treatment strategies in early rheumatoid arthritis and prevention of rheumatoid arthritis. Curr Rheumatol Rep. 2012;14(5):472-480.
-
- Smolen JS, Landewé R, Bijlsma J, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017;76(6):960-977.
-
- Scott DL, Symmons DP, Coulton BL, Popert AJ. Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet. 1987;329(8542):1108-1111.
-
- Möttönen T, Paimela L, Leirisalo-Repo M, Kautiainen H, Ilonen J, Hannonen P. Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategy. Ann Rheum Dis. 1998;57(9):533-539.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical